153 related articles for article (PubMed ID: 17164652)
1. Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.
Kossiva L; Theodoridou M; Mostrou G; Vrachnou E; Le Deist F; Rieux-Laucat F; Kanariou MG
J Pediatr Hematol Oncol; 2006 Dec; 28(12):824-6. PubMed ID: 17164652
[TBL] [Abstract][Full Text] [Related]
2. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis.
Kanegane H; Vilela MM; Wang Y; Futatani T; Matsukura H; Miyawaki T
Pediatr Nephrol; 2003 May; 18(5):454-6. PubMed ID: 12736807
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome.
Heelan BT; Tormey V; Amlot P; Payne E; Mehta A; Webster AD
Br J Haematol; 2002 Sep; 118(4):1078-81. PubMed ID: 12199788
[TBL] [Abstract][Full Text] [Related]
5. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
[TBL] [Abstract][Full Text] [Related]
6. [The autoimmune lymphoproliferative syndrome: a disorder of programmed cell death].
Seegers D; Peña AS; Bouma G
Ned Tijdschr Geneeskd; 2004 Feb; 148(8):371-6. PubMed ID: 15032090
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Obzut DA; Axsom K; Choi JK; Goldsmith KC; Hall J; Hulitt J; Manno CS; Maris JM; Rhodin N; Sullivan KE; Brown VI; Grupp SA
Blood; 2006 Sep; 108(6):1965-71. PubMed ID: 16757690
[TBL] [Abstract][Full Text] [Related]
8. Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
Janić MD; Brasanac CD; Janković JS; Dokmanović BL; Krstovski RN; Kraguljac Kurtović JN
Pediatr Blood Cancer; 2009 Dec; 53(6):1117-9. PubMed ID: 19588524
[TBL] [Abstract][Full Text] [Related]
9. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.
Shenoy S; Arnold S; Chatila T
J Pediatr; 2000 May; 136(5):682-7. PubMed ID: 10802504
[TBL] [Abstract][Full Text] [Related]
10. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
11. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
Avila NA; Dwyer AJ; Dale JK; Lopatin UA; Sneller MC; Jaffe ES; Puck JM; Straus SE
Radiology; 1999 Jul; 212(1):257-63. PubMed ID: 10405750
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Worth A; Thrasher AJ; Gaspar HB
Br J Haematol; 2006 Apr; 133(2):124-40. PubMed ID: 16611303
[TBL] [Abstract][Full Text] [Related]
14. Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7+2 T>C) affecting the Fas gene.
Wei A; Cowie T
Eur J Haematol; 2007 Oct; 79(4):363-6. PubMed ID: 17725802
[TBL] [Abstract][Full Text] [Related]
15. Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.
Ströbel P; Nanan R; Gattenlöhner S; Müller-Deubert S; Müller-Hermelink HK; Kreth HW; Marx A
Am J Surg Pathol; 1999 Jul; 23(7):829-37. PubMed ID: 10403307
[TBL] [Abstract][Full Text] [Related]
16. Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
Rao VK; Dowdell KC; Dale JK; Dugan F; Pesnicak L; Bi LL; Hoffmann V; Penzak S; Avila NA; Fleisher TA; Puck JM; Straus SE
Am J Hematol; 2007 Dec; 82(12):1049-55. PubMed ID: 17674358
[TBL] [Abstract][Full Text] [Related]
17. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
Rao VK; Price S; Perkins K; Aldridge P; Tretler J; Davis J; Dale JK; Gill F; Hartman KR; Stork LC; Gnarra DJ; Krishnamurti L; Newburger PE; Puck J; Fleisher T
Pediatr Blood Cancer; 2009 Jul; 52(7):847-52. PubMed ID: 19214977
[TBL] [Abstract][Full Text] [Related]
18. Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
Sleight BJ; Prasad VS; DeLaat C; Steele P; Ballard E; Arceci RJ; Sidman CL
Bone Marrow Transplant; 1998 Aug; 22(4):375-80. PubMed ID: 9722073
[TBL] [Abstract][Full Text] [Related]
19. The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.
Deutsch M; Tsopanou E; Dourakis SP
Clin Rheumatol; 2004 Feb; 23(1):43-4. PubMed ID: 14749982
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
